CHADDS FORD, Pa. Endo Pharmaceuticals has appointed a new COO, the drug maker announced Friday.
Julie McHugh will assume her position as COO beginning Monday. Most recently, she was CEO and president of Nora Therapeutics, a venture capital-backed biotech startup developing therapies for implantation failure. Prior to working for Nora, she worked at Johnson & Johnson as company group chairwoman for the Global Virology Business Unit.
“I am very pleased to announce Julie’s appointment as our chief operating officer,” Endo president and CEO David Holveck said. “Julie is uniquely qualified to serve in this important role given her leadership experience in general management, strategic marketing, product management, sales leadership and portfolio planning.”